Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
In vitro Skin Corrosion Test / Skin Irritation Test (OECD TG 431/439 and GLP): irritating to skin (BASF SE 2021; 69V0281/20B042).
In Vitro Eye Irritation Test (OECD TG 492 and GLP): non-irritating to eyes (BASF SE 2021; 62V0281/20B045).
Key value for chemical safety assessment
Additional information
Skin Irritation
For the assessment of the skin irritation/corrosion potential of Santalol Oil, two assays (i.e. the Skin Corrosion Test (SCT) and the Skin Irritation Test (SIT) according to OECD TG 431/439 and GLP) were considered in an in vitro skin irritation and corrosion test strategy, since a single in vitro assay is not considered sufficient to cover the full range of a skin irritating/corrosion potential (BASF SE 2021; 69V0281/20B042).
In the SCT, the potential to cause skin corrosion was assessed by a single topical application of 50μL undiluted Santalol Oil to a reconstructed three-dimensional, human epidermis model (EpiDerm™). Two EpiDerm™ tissues were incubated with the test substance for 3 minutes and 1 hour, each. In addition, 50μL per tissue of a negative control (deionized water) and of a positive control (8 N KOH) were applied to two tissues each per exposure period. The relative mean viability of the tissues treated with Santalol Oil after an exposure period of 3 minutes was 107.9%, and 122.2% after an exposure period of 1 hour. The tissues treated with the positive control (8 N KOH) showed a relative mean viability of 7.5% (3-minute exposure) and 5.5% (1-hour exposure) reflecting the expected sensitivity of the tissues. Based on the results observed and by applying the evaluation criteria, it was concluded that Santalol Oil does not show a skin corrosion potential in the EpiDerm™ in vitro skin corrosion test method under the test conditions chosen.
In the SIT, the potential to cause dermal irritation was assessed by a single topical application of 30μL undiluted Santalol Oil to a reconstructed three-dimensional, human epidermis model (EpiDerm™). Three EpiDerm™ tissues were incubated with the test substance for 1 hour followed by a 42-hour post-incubation period. In addition, 30μL per tissue of a negative control (PBS) and of a positive control (5% SDS) were applied to three tissues each. The relative mean viability of the tissues treated with Santalol Oil determined after an exposure period of 1 hour with an about 42-hour post-incubation was 4.7%. The tissues treated with the positive control (5% SDS) showed a relative mean viability of 2.5% reflecting the expected sensitivity of the tissues.
The acceptance criteria for both assays were met and Santalol Oil was found to be unable to reduce MTT directly.
Based on the results observed and by applying the evaluation criteria, it was concluded that the Santalol Oil shows a skin irritation potential in the EpiDerm™ in vitro skin irritation and corrosion test strategy under the test conditions chosen.
Eye Irritation
In the chosen key study for eye irritation according to OECD TG 492 and GLP (BASF SE 2021; 62V0281/20B045), the potential of Santalol oil to cause ocular irritation was assessed by a single topical application of 50 μL undiluted test substance to a reconstructed three-dimensional human cornea model (EpiOcular™). Two EpiOcular™ tissues were incubated with the test substance for 30 minutes followed by a 2-hour post-incubation period. In addition, 50 μL per tissue of a negative control (deionized water) and a positive control (methyl acetate) were applied to two tissues each.
The relative mean viability of the tissues treated with Santalol oil was 95.4%. The variability between the results of the tissues is within the acceptance range. The tissues treated with the positive control methyl acetate showed a relative mean viability of 25.8%, reflecting the expected sensitivity of the tissues. The mean OD570 of the negative control (deionized water) fulfilled the acceptance criteria and demonstrated the validity of the assay.
The test substance is not able to reduce MTT directly.
When using the currently available methods to assess the eye irritation potential of Santalol Oil, a single in vitro assay may not sufficient to cover the full range of eye irritation potential. In line with the in vitro eye irritation test strategy, two assays are considered relevant, i.e. The Bovine Corneal Opacity and Permeability Test (BCOP) and the EpiOcularTM Eye Irritation Test. In the current case the results derived with EpiOcularTM alone were sufficient for a final assessment. Therefore, further testing with BCOP was waived.
Based on the results observed and by applying the evaluation criteria described, it was concluded that Santalol oil does not show an eye irritation potential in the EpiOcular™ in vitro eye irritation test and in the in vitro eye irritation test strategy under the test conditions chosen.
Justification for classification or non-classification
The present data on skin irritation fulfill the criteria laid down in regulation (EU) 1272/2008, and a classification as "skin irritant" (category 2) is warranted.
The present data on eye irritation do not fulfill the criteria laid down in regulation (EU) 1272/2008, and therefore, a non-classification is warranted.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.